Journal Information
Vol. 94. Issue 6.
Pages 415-417 (1 June 2021)
Vol. 94. Issue 6.
Pages 415-417 (1 June 2021)
Scientific Letter
Open Access
Encephalopathy, kidney failure and retinopathy. CoQ10 deficiency due to COQ8B mutation
Encefalopatía, fallo renal y retinopatía. Déficit de CoQ10 pormutación de COQ8B
Victor Adam Lanceta,
Corresponding author

Corresponding author.
, Yolanda Romero Salasb, María Luisa Justa Roldánb, María Concepción García Jiménezc, Gema Ariceta Iraolad
a Servicio de Pediatría, Hospital Obispo Polanco, Teruel, Spain
b Unidad de Nefrología Pediátrica, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain
c Unidad de Metabolopatías, Hospital Universitario Miguel Servet, Zaragoza, Spain
d Servicio de Nefrología Pediátrica, Hospital Vall d’Hebron, Barcelona, Spain
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Tables (1)
Table 1. Previously described COQ8B variants and published case series.
Full Text
Dear Editor:

Coenzyme Q10 (CoQ10) plays a crucial role in several cellular processes, such as such as energy production through the mitochondrial respiratory chain, β-oxidation of fatty acids and pyrimidine biosynthesis, and it is also one of the main cellular antioxidants. Its synthesis requires multiple enzymes encoded by different genes (PDSS1, PDSS2, COQ2, COQ4, COQ6, COQ8A, COQ8B and COQ9). Due to the ubiquity of CoQ10 and the fact that the tissue expression of enzymes needed for its synthesis is variable, the clinical spectrum of CoQ10 deficiency is very heterogeneous, with the disorder potentially manifesting with myopathy, psychomotor retardation (PMR), encephalopathy, cerebellar ataxia, retinopathy, pulmonary hypertension, myocardiopathy, steroid-resistant nephrotic syndrome (SRNS) and chronic kidney disease (CKD), depending on the involved gene.1

We present the case of a boy aged 6 years with a past history of febrile seizures and PMR of unknown aetiology admitted to hospital with hypertensive encephalopathy (blood pressure, 240/170mmHg). The parents reported the child had experienced asthenia, polyuria, polydipsia and foamy urine lasting 6 months and palpebral oedema in the past few days. A head computed tomography (CT) scan was performed, with normal findings. The evaluation revealed the presence of microscopic haematuria, nephrotic-range proteinuria (urine protein/creatinine ratio, 23mg/mg; normal range <0.2) and kidney failure with an estimated glomerular filtration rate of 4mL/min/1.73m2 (KDIGO 2012 stage 3). The ultrasound scan revealed a small renal size for age, loss of corticomedullary differentiation and increased echogenicity, findings suggestive of long-term renal disease. There was also evidence bilateral retinitis pigmentosa. Continuous venovenous haemodiafiltration was initiated to control hypervolemia and manage electrolyte abnormalities such as hyperphosphataemia and hyperkalaemia, and chronic haemodialysis was maintained for 3 months until the patient underwent transplantation of a kidney from a deceased donor, which was successful. Genetic testing for nephronophthisis (NPHP1–4) was negative. Later on, the evaluation was expanded with next-generation sequencing of 140 genes associated with renal diseases, which identified 2 novel compound heterozygous variants of gene COQ8B (ADCK4) (c.439T>C [p.Cys147Arg] and c.1035+2T>C [p.?]), one of the genes involved in the synthesis of CoQ10 (Table 1).

Table 1.

Previously described COQ8B variants and published case series.

Case series  N  Nucleotide change  Amino acid change  Ethnicity 
Ashraf et al.15  c.101G>A  p.W34*  European 
  c.954_956dup  pT319dup  European 
  c.532C>T  p.R178W  Arabic 
  c.645delT  P.F215Lfs*14  Algerian 
  c.1430G>A  p.R477Q  Algerian 
  c.857A>G  p.D286G  Unknown 
  c.1447G>T  p.E483*  Unknown 
  c.958C>T  p.R320W  Tunisian 
  c.1027C>T  p.R343W  Moroccan 
  c.1199-1200insA  p.H400Nfs*11  Turkish 
  c.1356-1362del  p.Q452Hfs  Indian 
Korkmaz et al.26  c.293T>G  p.L98R  Turkish 
  c.929C>T  p.P310L  Turkish 
  c.1493-1494CC>AA  p.A498E  Turkish 
  c.1339dupG  p.E447Gfs*10  Turkish 
Li et al.  c.625C>G  p.D209H  Chinese 
Wang et al.c.241G>T  p.E81*  Chinese 
  c.1468C>T  p.R490C  Chinese 
  c.448C>T  P.R150*  Chinese 
  c.748G>C  p.D250H  Chinese 
  c.737G>A  p.S246N  Chinese 
Feng et al.  c.614C>T  p.S205N  Chinese 
Current studyc.439T>C)  p.C147R  European 
  c.1035+2T>C  p.(¿)  European 

The mutation does not result in an amino acid substitution but a stop codon.

On account of the genetic diagnosis, the patient started treatment with ubiquinone (5mg/kg/day), which improved psychomotor development and academic performance. At present, the patient is aged 12 years, the renal graft remains functional and his blood pressure is normal. The patient has not experienced any more seizures and treatment with anticonvulsants was discontinued successfully. In the physical examination, the patient continues to exhibit mild dysmetria in the finger-to-nose test and intention tremor in the hands despite normal findings of magnetic resonance imaging at age 11 years.

In CoQ10 deficiency, glomerular involvement, whether isolated or syndromic, is associated with changes in genes COQ2, COQ6, PDSS2 and COQ8B (ADCK4). Between 1% and 1.9% of cases of SRNS are due to CoQ10 deficiency associated with variants of these genes.

COQ8B encodes a kinase (aarF domain-containing kinase 4, ADCK4)2 expressed in mitochondria and in particular in pedicels, the proximal tubules and the collecting ducts. It also interacts with COQ6 at the podocyte level.3

Changes in the COQ8B gene lead to loss of function in ACDK4, resulting in decreased levels of CoQ10 and decreased podocyte migration in absence of proliferation or apoptosis of fibroblasts or in podocytes. At onset, which typically occurs in adolescence, 44% of patients present with SRNS and 46% with advanced CKD (stage 3–5).4 The renal histology is focal segmental glomerulosclerosis. Some patients also present with extrarenal manifestations, such as retinitis pigmentosa, convulsive seizures or PMR. Patients that have onset with SRNS may rapidly progress to terminal CKD and require a kidney transplant.

The administration of CoQ10 can improve symptoms, lower protein levels in urine and slow down the progression of CKD. Case series of CoQ10 deficiency caused by COQ8B variants (ADCK4) published to date have shown that 4 out of 43 patients had a partial or total response to this treatment.3–5 In 3 of these patients, renal disease was in the early stages.

Genetic testing including investigation of genes involved in the biosynthesis of CoQ10 should be considered in patients presenting with SRNS or CKD of unknown aetiology with or without extrarenal manifestations such as retinitis pigmentosa, convulsive seizures or PMR. It offers multiple benefits: an unequivocal molecular diagnosis for patients and their families, knowledge of the genotype-phenotype association and delivery of treatment which, if initiated early, may partially or completely halt the progression of renal and extrarenal disease. Genetic testing through multi-gene next generation sequencing panels with subsequent confirmation by Sanger sequencing is the most cost-effective approach at the moment.6

The case presented here illustrates the added value of genetic diagnosis in paediatric patients with severe CKD of unknown aetiology and the importance of identifying any associated abnormalities.

M.A. Desbats, G. Lunardi, M. Doimo, E. Trevisson, L. Salviati.
Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency.
J Inherit Metab Dis, 38 (2015), pp. 145-156
L. Vazquez Fonseca, M. Doimo, C. Calderan, M.A. Desbats, M.J. Acosta, C. Cerqua, et al.
Mutations in COQ8B (ADCK4) found in patients with steroid resistant nephrotic syndrome alter COQ8B function.
Hum Mut, 39 (2018), pp. 406-414
S. Ashraf, H.Y. Gee, S. Woerner, L.X. Xie, V. Vega-Warner, S. Lovric, et al.
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
J Clin Invest, 123 (2013), pp. 5179-5189
E. Korkmaz, B.S. Lipska-Zietkiewicz, O. Boyer, O. Gribouval, C. Fourrage, M. Tabatabaei, et al.
ADCK4-associated glomerulopathy causes adolescence-onset FSGS.
J Am Soc Nephrol, 27 (2016), pp. 63-68
C. Feng, Q. Wang, J. Wang, F. Liu, H. Shen, H. Fu, et al.
Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: case reports and literature review.
Medicine (Baltimore), 96 (2017), pp. e8880
S. Lovric, S. Ashraf, W. Tan, F. Hildebrandt.
Genetic testing in steroid-resistant nephrotic syndrome: when and how?.
Nephrol Dial Transplant, 31 (2016), pp. 1813-1821

Please cite this article as: AdánLanceta V, Romero Salas Y, Justa Roldán ML, García Jiménez MC, Ariceta Iraola G. Encefalopatía, fallo renal y retinopatía. Déficit de CoQ10 pormutación de COQ8B. An Pediatr (Barc). 2021;94:415–417.

Copyright © 2021. Asociación Española de Pediatría
Anales de Pediatría (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?